載入...

Selinexor in relapsed/refractory multiple myeloma

Multiple myeloma (MM) represents an incurable hematologic malignancy. Despite significant advances over the past decade, with the advent of multiple new classes of anti-myeloma agents, including immunomodulatory drugs, proteasome inhibitors and monoclonal antibodies, patients ultimately relapse. Sel...

全面介紹

Na minha lista:
書目詳細資料
發表在:Ther Adv Hematol
Main Authors: Richter, Joshua, Madduri, Deepu, Richard, Shambavi, Chari, Ajai
格式: Artigo
語言:Inglês
出版: SAGE Publications 2020
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7285937/
https://ncbi.nlm.nih.gov/pubmed/32566115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620720930629
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!